Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Prepaid Assets for 6 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 33.8% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 million, a 33.8% decrease, with the full-year FY2025 number at $3.0 million, down 33.8% from a year prior.
  • Prepaid Assets was $3.0 million for Q4 2025 at Lexicon Pharmaceuticals, down from $4.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.7 million in Q2 2024 to a low of $3.0 million in Q4 2025.
  • A 3-year average of $4.9 million and a median of $4.4 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 109.35% in 2024, then tumbled 52.65% in 2025.
  • Lexicon Pharmaceuticals' Prepaid Assets stood at $5.1 million in 2023, then fell by 11.66% to $4.5 million in 2024, then tumbled by 33.8% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for LXRX's Prepaid Assets are $3.0 million (Q4 2025), $4.1 million (Q3 2025), and $3.7 million (Q2 2025).